Market Value: immixbio.com (IMMX)

The price trajectory of Immix Biopharma, Inc. (IMMX) shown below helps assess the efficiency of a model where drug production is delegated to external CDMO partners to protect research in California. The business relies on unique patents for transporting drugs deep into tumors, creating a valuable asset. Meanwhile, the indicator stands at 0.58, considering current R&D expenses and the anticipated start of autoimmune disease trials, which the market currently prices in.

IMMX (Immix Biopharma Inc.) Market Capitalization history from 07/04/2022 to 11/13/2026

immixbio.com - analytical breakdowns and key metrics (IMMX)

- market price and analyst price targets:

Price Chart Immix Biopharma|IMMX - Consensus Target

- company stock exchange capitalization indicators:

Market Value Immix Biopharma, Inc.|IMMX - Real Price to Acquire Entire Company

- book value of equity indicators:

Accounting Value per Share Immix Biopharma|IMMX - Accounting Capitalization|Market Value to Book Value Ratio immixbio.com|IMMX - Company Assets

- debt level and financial liquidity data:

- net income and valuation multiples indicators:

IMMX - Company Net Income|Projected Future Earnings Immix Biopharma, Inc.|IMMX - Market Cap to Net Income Ratio|Projected Price to Earnings Immix Biopharma|IMMX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Immix Biopharma, Inc.|IMMX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Immix Biopharma|IMMX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months immixbio.com|IMMX - Net earnings per share growth this year|Net earnings per share growth forecast for next year Immix Biopharma, Inc.

Analysis of all company metrics:IMMX (Immix)

Investors are seeking fundamental benchmarks to assess the real value of the business. This metric represents the product of the current share price and the total number of outstanding shares. The aggregate market capitalization of Immix Biopharma, Inc. (IMMX) reflects the market consensus regarding future cash flows. For Immix Biopharma, Inc. (IMMX), this figure confirms the capitalization of the intellectual capital of a cohesive team of immunologists. The stability of the valuation underscores market confidence in the success of ongoing clinical trials.

Competitor analysis